Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Is a
Allocation Type
NA
0
Intervention Model
Single Group Assignment
0
Intervention Name
Viralym-B
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Biological
0
Last Updated
April 9, 2018
0
Masking Type
None (Open Label)
0
Primary Completion Date
2019
0
Trial Recruitment Size
0
0
Trial Sponsor
Clinical Trial Start Date
March 1, 2018
0
Study Completion Date
2019
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
0
Official Website
Find more entities like Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
